Annexon (ANNX) to Release Quarterly Earnings on Tuesday

Annexon (NASDAQ:ANNX) is expected to post its quarterly earnings results before the market opens on Tuesday, March 25th. Analysts expect Annexon to post earnings of ($0.28) per share for the quarter.

Annexon (NASDAQ:ANNX) last announced its earnings results on Monday, March 3rd. The company reported ($0.33) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.05). On average, analysts expect Annexon to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Annexon Stock Performance

Shares of NASDAQ:ANNX opened at $2.40 on Friday. The company has a market cap of $263.30 million, a P/E ratio of -2.29 and a beta of 1.14. Annexon has a one year low of $2.30 and a one year high of $8.40. The business’s 50-day simple moving average is $3.25 and its 200 day simple moving average is $5.10.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. HC Wainwright reiterated a “buy” rating and set a $30.00 target price on shares of Annexon in a report on Tuesday, December 17th. Needham & Company LLC reiterated a “buy” rating and set a $16.00 target price on shares of Annexon in a report on Tuesday, March 4th. Six research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $15.80.

Annexon Company Profile

Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis.